Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Net Margin (2021 - 2025)

PAVmed (PAVM) has 5 years of Net Margin data on record, last reported at 126560.0% in Q3 2025.

  • For Q3 2025, Net Margin changed N/A year-over-year to 126560.0%; the TTM value through Sep 2025 reached 2796.55%, changed N/A, while the annual FY2024 figure was 1081.6%, 378429.0% up from the prior year.
  • Net Margin reached 126560.0% in Q3 2025 per PAVM's latest filing, up from 176316.67% in the prior quarter.
  • Across five years, Net Margin topped out at 237650.0% in Q1 2021 and bottomed at 176316.67% in Q2 2025.
  • Average Net Margin over 5 years is 3499.14%, with a median of 5761.67% recorded in 2021.
  • Peak YoY movement for Net Margin: tumbled -24661296bps in 2022, then skyrocketed 22350624bps in 2025.
  • A 5-year view of Net Margin shows it stood at 5761.67% in 2021, then plummeted by -218bps to 18332.14% in 2022, then soared by 92bps to 1516.21% in 2023, then tumbled by -958bps to 16040.0% in 2024, then tumbled by -689bps to 126560.0% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 126560.0% in Q3 2025, 176316.67% in Q2 2025, and 221250.0% in Q1 2025.